<bill session="116" type="h" number="1614" updated="2022-11-01T17:17:21Z">
  <state datetime="2019-03-07">REFERRED</state>
  <status>
    <introduced datetime="2019-03-07"/>
  </status>
  <introduced datetime="2019-03-07"/>
  <titles>
    <title type="display">John S. McCain Opioid Addiction Prevention Act</title>
    <title type="official" as="introduced">To amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes.</title>
    <title type="short" as="introduced">John S. McCain Opioid Addiction Prevention Act</title>
  </titles>
  <sponsor bioguide_id="K000386"/>
  <cosponsors>
    <cosponsor bioguide_id="B001284" joined="2019-11-19"/>
    <cosponsor bioguide_id="C001092" joined="2019-06-20"/>
    <cosponsor bioguide_id="L000590" joined="2019-06-20"/>
    <cosponsor bioguide_id="M001205" joined="2019-09-24"/>
    <cosponsor bioguide_id="P000616" joined="2019-05-30"/>
    <cosponsor bioguide_id="R000610" joined="2019-11-22"/>
    <cosponsor bioguide_id="S001201" joined="2019-03-07"/>
  </cosponsors>
  <actions>
    <action datetime="2019-03-07">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-03-07" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-03-07">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-03-08">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2019-04-12">
      <text>Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSJU" name="House Judiciary" subcommittee="" activity="Referral"/>
    <committee code="HSJU08" name="House Judiciary" subcommittee="Crime and Federal Government Surveillance" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="s" number="724" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Crime and law enforcement"/>
    <term name="Drug therapy"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Health personnel"/>
    <term name="Licensing and registrations"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2019-09-18T12:11:45Z" status="Introduced in House">John S. McCain Opioid Addiction Prevention Act

This bill establishes a new registration requirement for practitioners who are licensed to prescribe controlled substances in schedule II, III, or IV.

Specifically, a practitioner must agree to limit the supply of opioids prescribed for the initial treatment of acute pain, as a condition of obtaining or renewing a registration through the Drug Enforcement Administration.

An opioid that is approved and prescribed for the treatment of addiction is not subject to the limit.</summary>
</bill>
